Literature Scan

Search Strategy
We conducted a literature search to identify cost data collection tools used in studies focused on micro-costing intervention costs of prevention and management interventions targeting noninfectious chronic conditions, including noncommunicable chronic diseases, mental health conditions, and behavioral risk factors (tobacco use, alcohol and other substance abuse, physical inactivity, nutrition, obesity).
We recruited a library specialist to conduct a database search based on our intended literature review. The librarian searched the databases Medline, PsychInfo, and Econ lit on 1/26/18 using the search terms contained in Appendix Table 1 . Concurrently, we searched PubMed on 1/27/18 using the search terms contained in Appendix Table 1 .
We combined all records retrieved from all database searches and removed duplicates in EndNote. We did a first round of screening titles and abstracts of all collected records and excluded 1) reviews, commentaries, or theses; 2) study protocols, designs, or rationales; and 3) otherwise obviously irrelevant. In a second round of screening titles and abstracts, we excluded those that 1) did not address noninfectious chronic conditions; 2) were not about a prevention or management intervention (e.g., focused on a specific treatment, clinical procedures, or medications); and 3) did not appear to focus on assessing intervention costs through direct measurement micro-costing, such as those using modeling or lacking adequate focus on intervention cost. We then reviewed the screened articles for inclusion in our review and excluded those that 1) did not use direct measurement micro-costing of intervention costs or did not provide adequate detail to assess data collection; and 2) appeared to use or were described as using direct measurement micro-costing but did not provide adequate detail on the process by which micro-costing data were collected in order to identify data collection tools.
In all, 2,082 records were returned from the database searches after duplicates were removed.
After screening, 306 studies remained, of which 93 studies met the criteria to be included in the review to identify cost data collection tools used (Appendix Figure 1) .
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Abstraction and Analysis
One coder reviewed the 93 studies and abstracted the original descriptions of the cost data collection tools used in each study, as well as information on how each tool was used (e.g., mode, main user) when available. The described cost data collection tools were then listed and combined into emergent categories and sub-categories. Information on the study type, study perspective, intervention setting, intervention type, and health targets was also abstracted and subsequently combined into emergent categories. Frequencies of use of each data collection tool were then calculated for each of these study and intervention characteristics categories (Appendix Table 2 ("Cost analysis" OR "cost analyses" OR "cost allocation" OR "health expenditure*" OR "cost-benefit analysis" OR "economic analysis" OR "economic analyses" OR (program* N2 cost*) OR (cost* N2 prevention) OR (cost* N2 intervention*)) AND (Intervention* OR prevention OR (health N2 program*) OR "health education" OR "government program*") AND "Chronic Illness" OR "Heart Disorders" OR "Community Health" OR "Community Services" OR "Diabetes Mellitus" OR Hypertension OR "Physical
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Fitness" OR exercise OR obesity OR "weight loss" OR "Weight Control" OR "Smoking Cessation" OR "Cancer Screening" OR "Drug Abuse" OR "Drug Addiction" OR Alcoholism OR "Mental Health Services"
English ; 2008-
PubMed [Title/Abstract]("economic evaluation" OR "cost analysis" OR "budget impact" OR "program* cost" OR "intervention cost" OR "cost study" OR "implementation cost" OR "micro-costing" OR "activity-based cost") AND The percentages represent the proportion of studies in that column that used a particular cost data collection tool. a. Provider perspective category includes those which focus on the perspective of an entity which would deliver the intervention, including perspectives of the healthcare system, government, and individual providing organizations (e.g., school, employer). b. Includes two studies that took the perspective of just the intervention participants and caregivers. c. Studies' use of tools was not mutually exclusive; 51 (55%) studies described using only one category of data collection tools, 42 (45%) described using two or more categories of tools. Therefore, column percentages do not sum to 100%. The percentages represent the proportion of studies in that column that used a particular cost data collection tool. a. Settings are not mutually exclusive. For example, if an intervention was first delivered in a healthcare setting and then followed up with telephone counseling or home visits, the intervention was counted as being in both a healthcare and community setting. b. Intervention types are not mutually exclusive. Some studies examined programs that targeted both the prevention and management of chronic conditions. c. Studies' use of tools was not mutually exclusive; 51 (55%) studies described using only one category of data collection tools, 42 (45%) described using two or more categories of tools. Therefore, column percentages do not sum to 100%. d. Community-based setting includes all interventions delivered outside a healthcare setting, including in-person interventions in a community setting, telephone-based, or web-based interventions. e. Healthcare-based setting includes hospital, hospital clinics, community clinics, academic medical centers.
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